Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Visualizes a World with Superior Bladder Cancer Surgical Procedures
Surgical imaging company Imagin Medical Inc. has developed a proprietary technology that enhances surgeons’ efforts to identify the full extent of bladder cancers and remove them Imagin’s i/Blue Imaging (TM) System uses blue light in combination with a fluorescent contrasting agent that highlights the tumor on an endoscope’s camera display to help surgeons remove the cancerous cells more completely than the white light standard Bladder cancer is the fourth most common cancer in men and the second most common genitourinary cancer The American Cancer Society forecasts that, during this year, about 81,400 new cases of bladder cancer would be reported…